New global consumer research from Kerry, a global leader in taste and nutrition, reveals that consumers are concerned about the long-term negative effects of high sugar intake. Health, with a focus on improving immunity, gut health, and mental wellness, is the primary reason consumers are taking steps to cut back on how much sugar they consume. In Southeast Asia, as many as 86 percent of respondents are concerned about overconsumption of sugar leading to diabetes. More than 70 percent want to … [Read more...] about Sensibly Sweet research shows long-term health concerns motivate sugar reduction in diets
Kerry
Sporevia probiotic can reduce staph colonization by more than 95%, study finds
Kerry Group’s probiotic strain Sporevia (Bacillus subtilis MB40) can eliminate Staphylococcus aureus in the human body by more than 95 percent, a clinical trial has found. Staphylococcus aureus (S. aureus), commonly known as “staph,” is a pathogen that caused over 119,000 infections and nearly 20,000 deaths in the US in 2017.1 However, the use of oral antibiotics for staph decolonization is advised against because of its effect on the gut microbiota and antibiotic resistance.2 Sporevia … [Read more...] about Sporevia probiotic can reduce staph colonization by more than 95%, study finds
Kerry and c-LEcta enter agreement to market DENARASE® products
28 February 2023: Kerry, a world leader in taste and nutrition, and c-LEcta, a leading biotechnology company in enzyme engineering and bioprocess development, have announced a new partnership to jointly market DENARASE® products. The DENARASE® product family was launched in 2012 and applied in hundreds of clinical and commercial production processes for gene/cell therapies and vaccines. Combining Kerry and c-LEcta’s expertise in the biopharma and pharmaceutical sectors, the partnership will … [Read more...] about Kerry and c-LEcta enter agreement to market DENARASE® products